Universal Health Realty Income Trust (UHT) — Fair Value Analysis

Base-case fair value (P50): $42.63 · Current price: $39.75 · Verdict: Fairly Valued

The Verdict on UHT

Based on our Monte Carlo simulations, UNIVERSAL HEALTH REALTY INCOME TRU (UHT) is currently assessed as Fairly Valued. The analysis indicates a median fair value (P50) of $42.63, standing at a modest +7.2% above its current trading price of $39.75. This suggests that UHT's market price largely aligns with its intrinsic value as derived from thousands of forward-looking financial scenarios. While there is a slight indicated upside, the overall picture points to a stock trading near its fair equilibrium, according to our probabilistic modeling. This valuation considers a wide range of potential outcomes for UHT's future financial performance.

How UHT stacks up against peers

Our quality tier assessment for UHT is currently unrated, indicating that a direct, categorized comparison of its operational and financial health against sector peers is not available through this specific metric. While the Monte Carlo simulation provides an intrinsic fair value of $42.63 relative to $39.75, the absence of a quality rating means investors should conduct additional fundamental due diligence. The unrated status highlights that while our model identifies a +7.2% potential based on its internal financials, broader market positioning against competitors is not factored into this specific tier.

What this means for investors

For investors considering UHT, the "Fairly Valued" verdict signals that the stock, at $39.75, offers a calculated median upside to $42.63 of +7.2%. This implies that while significant undervaluation is not present, there's a slight buffer towards the simulated fair value. Investors seeking deep value may find the +7.2% modest, while those prioritizing stability might appreciate the alignment. Our simulations also account for a full spectrum of outcomes, from potential downside scenarios to more optimistic bull cases beyond the median $42.63. For a deeper dive into UHT's full bear-case and bull-case distribution, FairCurve provides comprehensive insights. Sign up for a free FairCurve account to see the full bear/bull distribution and track UHT's fair value as new fundamentals are released.

Frequently Asked Questions

Is UHT overvalued or undervalued right now?

Based on our Monte Carlo simulations, UHT is assessed as Fairly Valued. The median fair value (P50) of $42.63 indicates a modest upside compared to its current price of $39.75.

What is the bear case and bull case for UHT?

The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of achieving upside, is available with a free FairCurve account.

How does FairCurve calculate UHT's fair value?

FairCurve calculates UHT's fair value using sophisticated Monte Carlo simulations, modeling thousands of forward scenarios to determine a probabilistic distribution of potential future values.

How can I track UHT's fair value as it changes?

You can add UHT to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts when new earnings or fundamental data are released.